Cargando…
Clinical improvement after treatment with VEGF(165) in patients with severe chronic lower limb ischaemia
The present study focuses on the application of a therapeutic strategy in patients with chronic severe lower limb ischaemia using a plasmid vector encoding the vascular endothelial growth factor (phVEGF(165)). It has been shown that VEGF promotes neo-vascularization and blood vessel network formatio...
Autores principales: | Anghel, Andrei, Mut-Vitcu, Bogdan, Savu, Lorand, Marian, Catalin, Seclaman, Edward, Iman, Raluca, Neghina, Adriana-Maria, Dragulescu, Stefan I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276892/ https://www.ncbi.nlm.nih.gov/pubmed/18923928 http://dx.doi.org/10.1007/s11568-007-9006-5 |
Ejemplares similares
-
The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF(165) and downregulating VEGF(165b)
por: Quan, Bingxuan, et al.
Publicado: (2023) -
Acute Lower Limb Ischaemia in COVID19 Patients
por: Spinelli, D., et al.
Publicado: (2023) -
VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010) -
Depression influences the quality of diabetes-related self-management activities in elderly patients with type 2 diabetes: a cross-sectional study
por: Mut-Vitcu, Gabriela, et al.
Publicado: (2016) -
The role of VEGF-A(165)b in trophoblast survival
por: Bills, Victoria L, et al.
Publicado: (2014)